Menu

Biofuels by the Numbers

Of the many available no- or low-carbon methods to harvest energy, including wind, geothermal, hydroelectric, and solar approaches, conversion of plant biomass to liquid fuels is the most cost-effective strategy.

Jul 1, 2012
Heather Youngs and Chris Somerville

Infographic: Biofuels by the Numbers
View full size JPG | PDF
LUCY READING - IKKANDA

Of the many available no- or low-carbon methods to harvest energy, including wind, geothermal, hydroelectric, and solar approaches, conversion of plant biomass to liquid fuels is the most cost-effective strategy, currently contributing 78 percent of the total renewable energy worldwide. While some are concerned that an increased dependence on energy crops will be at odds with the use of land for production of food and feed, the next 25 years could see biofuels rise to the challenge.

Read the full story.

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.